Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  altretamine
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-25 of 112 for your search:
Start Over
Phase II-III Chemotherapy with Hexamethylmelamine and L-Phenylalanine Mustard for Stage III and IV Ovarian Carcinoma
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: DFCI-75118
Phase II-III HMM vs FAC (5-FU/ADR/CTX) Chemotherapy for Advanced Transitional Cell Bladder Cancer with Impaired Renal Function
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-7904
Phase II/III Chemotherapy and Hormone Therapy with ADR/VCR/DBD/PRED Followed by TMX/FXM/BLEO/HMM/MTX-CF for Metastatic Stage III/IV or Recurrent Breast Carcinoma
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: under 65
Sponsor:
Protocol IDs: WCCC-CO-7711R, NCI-D80-048-183
CACP/HMM vs CACP/HMM/MPA for Advanced Epithelial Ovarian Tumor - A Phase III Study
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: NCI-D79-019-073, BUCRC-751
Phase III Study of Chemotherapy with ADR/CCNU/HMM/MTX and Amphotericin B for Advanced non-Small Cell Bronchogenic Carcinoma
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: CHNMC-COH-CA-LUN-1, NCI-D80-035-131
Phase III CTX/ADR/VCR Therapy Alone or with Radiotherapy Followed by VP-16/HMM or MTX/CF/VP-16/HMM for Small Cell Lung Cancer
Phase: Phase III
Type: Treatment
Status: Closed
Age: under 75
Sponsor:
Protocol IDs: SEG-78LUN328
Phase III Sequential Chemotherapy with CTX, HMM, ADR for Recurrent or Advanced Squamous Cell Carcinoma of the Cervix
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MDAR-30
Phase III Combination Chemotherapy with L-PAM/CACP vs HAC (HMM/ADR/CTX) for Epithelial Ovarian Carcinoma
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MDA-G-7804
Phase III Single-Agent Therapy with L-PAM or CACP and Combination Chemotherapy with HMM/CTX/ADR for Advanced Stage III/IV Cancer of the Ovary
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MDAR-64, MDA-13, MDA-14
Phase III Combination Chemotherapy with CTX/VP-16/HMM for Small Cell Lung Carcinoma, plus Radiotherapy for Patients with Limited Disease
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: NCI-D80-026-053, RPMI-PPC-463
Phase III Intensive Cyclic Chemotherapy with CTX/ADR/VCR and VP-16/HMM/MTX Followed by Radiotherapy for Limited or Extensive Small Cell Carcinoma of the Lung
Phase: Phase III
Type: Treatment
Status: Closed
Age: under 70
Sponsor:
Protocol IDs: NCI-D81-017-514, JHH-8110
Phase III MACC (MTX/ADR/CCNU/CTX) vs MACC/Warfarin vs MACC Alternating with MEPH (MITO/VP-16/CACP/HMM) for Extensive Small Cell Lung Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: 21 to 69
Sponsor: NCI
Protocol IDs: CLB-8084, CALGB-8084
Phase III CAV (CTX/ADR/VCR) vs CAV Alternating with HEM (HMM/VP-16/MTX) with/without Maintenance for Extensive Small Cell Lung Carcinoma
Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-1582
Phase III Chemotherapy with HMM and High-Dose vs Low-Dose CACP, with or without VIT-B6, for Stage III/IV Ovarian Cancer (Summary last modified 06/97)
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-2879R
Phase III Chemotherapy with SMF (SZC/MITO/5-FU) vs HexMF (HMM/MITO/5-FU) for Locally Unresectable or Metastatic Pancreatic Carcinoma
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: GITSG-9382
Phase III CACP/CTX vs HMM for Residual, non-Measurable Stage III Ovarian Adenocarcinoma Responsive to Prior CACP/CTX
Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: GOG-61
Phase III L-PAM vs Hexa-CAP (HMM/CTX/ADR/CACP), with Crossover for Failures, for Resected, Stage III/IV Epithelial Ovarian Carcinoma
Phase: Phase III
Type: Supportive care, Treatment
Status: Closed
Age: 70 and under
Sponsor:
Protocol IDs: UCCRC-2627, NCI-D78-014-185
Phase III Sequential Chemotherapy with VAPE (VCR/ADR/PCB/VP-16), CMC (CTX/MTX/CCNU), and HMVlb (HMM/MITO/VBL) for Limited and Extensive Small Cell Lung Cancer
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: NCI-D80-009-324, PCCC-8024
Phase III Combination Chemotherapy with L-PAM/CACP vs L-PAM/CACP Alternating with HAC (HMM/ADR/CTX) for Metastatic Epithelial Ovarian Carcinoma
Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor:
Protocol IDs: NCI-D82-043-187, MDA-G-8102
Phase III Combination Chemotherapy with MEPH (MITO/VP-16/CACP/HMM) Alternating with MACC (MTX/ADR/CTX/CCNU) for Inoperable Lung Cancer
Phase: Phase III
Type: Treatment
Status: Closed
Age: under physiologic 70
Sponsor:
Protocol IDs: NCI-D82-055-883
Phase III CAP (CTX/ADR/CACP) vs Drugs Selected by Human Tumor Stem Cell Assay for Stage III/IV Ovarian Carcinoma
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: POA-83182, WFU-83182
Phase III Chemotherapy with HCAP (CTX/ADR/CACP/HMM) vs CP (CTX/CACP) for Stage III/IV Ovarian Carcinoma
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MAYO-806151
Start Over